Diabetes Technology

Novel Deep Learning System May Help Identify Diabetic Retinopathy

Novel Deep Learning System May Help Identify Diabetic Retinopathy

A novel deep learning system has high sensitivity and specificity for identifying diabetic retinopathy.

Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined

Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined

By

In this phase 3 study, statistically and clinically meaningful improvements in HbA1c, body weight, and the proportion of patients achieving goal HbA1c <7% (53mmol/mol) were demonstrated with 2 doses of ITCA 650 vs placebo.

New Continuous Glucose Monitoring System Now Available for Medicare Patients

New Continuous Glucose Monitoring System Now Available for Medicare Patients

By

A new continuous glucose monitoring system that allows patients to capture real-time glucose readings without use calibration or routine fingersticks is now available.

New Insulin Pen With Smartphone App, Bolus Advisor Available

New Insulin Pen With Smartphone App, Bolus Advisor Available

By

The system is able to calculate and recommend optimal insulin dose, track the timing of doses, monitor insulin temperature, remind users to take insulin, and create reports for the healthcare provider.

New Consensus Recommendations on Use of Continuous Glucose Monitoring

New Consensus Recommendations on Use of Continuous Glucose Monitoring

By

The Advanced Technologies & Treatments for Diabetes (ATTD) Congress summarize consensus recommendations on the current understanding of how CGM results can affect outcomes.

Standard Care vs Telemedicine for Diabetic Foot Ulcer Follow-up Care

Standard Care vs Telemedicine for Diabetic Foot Ulcer Follow-up Care

By

Patients from 3 sites participated in a trial examining the noninferiority of telemedicine vs standard outpatient care for diabetic foot ulcer follow-up treatment.

Effect of SGLT2 Inhibitors on Early Metabolic Decompensation in T1D

Effect of SGLT2 Inhibitors on Early Metabolic Decompensation in T1D

By

Patients with T1D are not susceptible to accelerated lipolysis and ketogenesis, despite the reduction in overnight basal insulin doses during SGLT2i treatment.

Real-Time Continuous Glucose Monitoring Beneficial But Challenges Remain

Real-Time Continuous Glucose Monitoring Beneficial But Challenges Remain

By

Although sharing of real-time continuous glucose monitoring data can create tension between patients with type 1 diabetes and family members, it can also facilitate greater empowerment and perceptions of safety among both patients and their caregivers.

Predictive Glucose Management Systems May Reduce Hypoglycemia in Pediatric Diabetes

Predictive Glucose Management Systems May Reduce Hypoglycemia in Pediatric Diabetes

By

A study examined the efficacy and safety of predictive low-glucose management systems for the prevention of hypoglycemia in adolescents with type 1 diabetes.

Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D

Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D

By

Participants reported improvements in many psychosocial variables associated with using an automated bihormonal bionic pancreas system relative to self-management of diabetes using their own insulin pump.

Remotely Connected Diabetes System Improves Glycemic Control in Insulin-Treated Diabetes

Remotely Connected Diabetes System Improves Glycemic Control in Insulin-Treated Diabetes

By

A remotely connected diabetes management system increased patent satisfaction and improved glycemic control in patients with insulin-treated diabetes.

Effect of Prior Glucose Monitoring on Glycemic Outcomes With a Hybrid Closed-Loop System

Effect of Prior Glucose Monitoring on Glycemic Outcomes With a Hybrid Closed-Loop System

By

Patients with prior experience using a continuous glucose monitoring system may benefit from the MiniMed 670G HCL system therapy.

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Children

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Children

By

Recommendations for utilizing trend arrow data in a mobile continuous glucose monitoring system were recently issued for pediatric patients with type 1 diabetes.

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Adults

Utilizing Trend Arrow Data in CGM Systems to Manage Diabetes in Adults

By

Interpreting trend arrow data from continuous glucose monitoring may provide additional data to improve glycemic control in adults with diabetes mellitus.

Does Professional CGM Decrease the Economic Burden of T2D?

Does Professional CGM Decrease the Economic Burden of T2D?

By

Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.

Novel Adaptive Artificial Pancreas Improves HbA1c and Reduces Hypoglycemia

Novel Adaptive Artificial Pancreas Improves HbA1c and Reduces Hypoglycemia

By

Adapting open-loop settings that are used by the artificial pancreas algorithm is easily understandable and transparent to both patients and physicians.

Efficacy of CGM in Preterm Infants of Mothers With Diabetes

Efficacy of CGM in Preterm Infants of Mothers With Diabetes

By

Real-time continuous glucose monitoring systems are comparable to traditional blood glucose monitoring methods in preterm infants.

EASD, ADA Recommendations Aimed at Improving Safety, Efficacy of CGM

EASD, ADA Recommendations Aimed at Improving Safety, Efficacy of CGM

By

With this statement, researchers hope to improve safety and efficacy outcomes, advance technology, and improve patient quality of life and health outcomes.

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging

By

Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.

No Fingerstick Necessary: FDA Approves Novel CGM System for Diabetes

No Fingerstick Necessary: FDA Approves Novel CGM System for Diabetes

By

New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.

Algorithm Produces Personalized Glucose Forecast for Patients with T2D

Algorithm Produces Personalized Glucose Forecast for Patients with T2D

Machines were used to examine the glycemic impact of various meals to determine a glucose forecast.

NIH Announces Major Artificial Pancreas Clinical Trials

NIH Announces Major Artificial Pancreas Clinical Trials

By

The studies will assess the safety, efficacy, and user-friendliness among other aspects, of multiple artificial pancreas devices.

Continuous Glucose Monitoring Improves HbA1c in T1D

Continuous Glucose Monitoring Improves HbA1c in T1D

By

Patients with type 1 diabetes who used multiple insulin injections daily experienced reductions in HbA1c with continuous glucose monitoring.

FDA Expands Indication for Dexcom G5 Continuous Glucose Monitoring System

FDA Expands Indication for Dexcom G5 Continuous Glucose Monitoring System

By

The FDA's expanded indication for the Dexcom G5 Continuous Glucose Monitoring System allows for replacement of fingerstick glucose testing.

FDA: Continuous Glucose Monitoring Insulin Pump Approved for Pediatric Patients With Diabetes

FDA: Continuous Glucose Monitoring Insulin Pump Approved for Pediatric Patients With Diabetes

By

The system allows patients and their caregivers to access glucose measurements through their pump or through a mobile app.

Contour Next One Glucose Monitoring System Approved by FDA

Contour Next One Glucose Monitoring System Approved by FDA

By

The Contour®Next One Blood Glucose Management System will be available in early 2017.

Implantable Continuous Glucose Monitor Safe, Effective in Diabetes

Implantable Continuous Glucose Monitor Safe, Effective in Diabetes

By

An implantable continuous glucose monitor appears to be a safe and effective alternative to a transcutaneous monitor in diabetes.

The 'Artificial Pancreas' Has Arrived

The 'Artificial Pancreas' Has Arrived

By

FDA approval of the first closed-loop insulin delivery system is exciting for both physicians and patients. What does this mean for the future?

FDA Green-lights First 'Artificial Pancreas' for Type 1 Diabetes

FDA Green-lights First 'Artificial Pancreas' for Type 1 Diabetes

By

Approval was based on a clinical trial that included 123 people with type 1 diabetes who used the MiniMed 670G hybrid closed-loop system for 3 months, after a 2-week period of no use.

Artificial Pancreas Moving Steadily Toward Commercial Approval

Artificial Pancreas Moving Steadily Toward Commercial Approval

By

The FDA is coordinating with investigators, manufacturers, clinicians, and others to bring automated insulin delivery devices to market.

Sign Up for Free e-Newsletters

CME Focus